Jinhe Biotechnology
Dalian Shi
About Jinhe Biotechnology
Jinhe Biotechnology Co., Ltd. is a publicly listed company specialized in producing veterinary medicines. After almost 30 years’ development, it is today a world leader in various specifications and kinds of Chlortetracycline with an annual yield of 55000 tons and the products as Chlortetracycline Hydrochloride also rank in front of the industry. There are advanced fermentation and test equipments in the production area and all the manufacturing process is automatically controlled by computer system. Now the company has a fermention capacity of 5800m³ which ranks in front in today’s world.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 1,001 – 5,000
- Funding stage: IPO
- Last round: Post-IPO Equity (Mar 2023)
- Ticker: szse:002688
- Website: jinhe.com.cn
- Phone: 0471-8511111
Industries & Categories
Health Care, Manufacturing, Medical, Veterinary
Social Profiles
Canonical: https://fsome.com/organization/jinhe-biotechnology-2022213 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.